Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Dr. Barnes brings more than 25 years of biotech leadership expertise and a proven track record in advancing transformative early-stage therapies